Issue 4/2012
Content (19 Articles)
Letter to the Editor: Interobserver Variability of Heart-to-Mediastinum Ratio in I-123 MIBG Sympathetic Imaging
- Open Access
- Letter to the Editor
Ben F. Bulten, Roel L. F. van der Palen, Hanneke W. M. van Laarhoven, Livia Kapusta, Annelies M. C. Mavinkurve-Groothuis, Lioe-Fee de Geus-Oei
Reply to the letter by Ben F. Bulten et al. regarding “Interobserver Variability of Heart-to-Mediastinum Ratio in I-123 MIBG Sympathetic Imaging”
- Letter to the Editor
Wengen Chen, Qi Cao, Vasken Dilsizian
Can Bridge to Recovery Help to Reveal the Secrets of the Failing Heart?
- Invited Commentary
Michael Ibrahim, Cesare Terracciano, Magdi H. Yacoub
Initial Strategy of Revascularization Versus Optimal Medical Therapy for Improving Outcomes in Ischemic Heart Disease: A Review of the Literature
- Ischemic Heart Disease (S Brener, Section Editor)
A. Vincent Songco, Sorin J. Brener
Late Stent Thrombosis: The Last Remaining Obstacle in Coronary Interventional Therapy
- Ischemic Heart Disease (S Brener, Section Editor)
Piera Capranzano, George Dangas
Preservation of Myocardium During Coronary Artery Bypass Surgery
- Ischemic Heart Disease (S Brener, Section Editor)
Takeshi Kinoshita, Tohru Asai
Periprocedural Myocardial Enzyme Elevation: Prognostic Implications for Current Practice
- Ischemic Heart Disease (S Brener, Section Editor)
Sanjum S. Sethi, Avtar Singh, Michael E. Farkouh
Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Antagonists in Atherosclerosis Prevention
- Ischemic Heart Disease (S Brener, Section Editor)
Maria M. Patarroyo Aponte, Gary S. Francis
Regression of Atherosclerosis
- Ischemic Heart Disease (S Brener, Section Editor)
Benoit J. Arsenault, Ekaterini A. Kritikou, Jean-Claude Tardif
New Anticoagulants in Ischemic Heart Disease
- Ischemic Heart Disease (S Brener, Section Editor)
Lawrence Rajan, David J. Moliterno
Platelet Function and Inhibition in Ischemic Heart Disease
- Ischemic Heart Disease (S Brener, Section Editor)
Annunziata Nusca, Giuseppe Patti
Revascularization for Left Main and Multivessel Coronary Artery Disease in the Drug-Eluting Stent Era: Integration of Recent Drug-Eluting Stent Trials
- Ischemic Heart Disease (S Brener, Section Editor)
Samip Vasaiwala, David O. Williams
Coronary Stent Choice in Patients with Acute Myocardial Infarction
- Management of Acute Coronary Syndromes (R Mehran, Section Editor)
Giulio G. Stefanini, Stephan Windecker
Which Antiplatelet Agent for Whom? Which Patient Populations Benefit Most from Novel Antiplatelet Agents (Ticagrelor, Prasugrel)?
- Management of Acute Coronary Syndromes (R Mehran, Section Editor)
Christoph Varenhorst, Stefan James
Which Antithrombin for Whom? Identifying the Patient Population that Benefits Most from Novel Antithrombin Agents
- Management of Acute Coronary Syndromes (R Mehran, Section Editor)
David A. Burke, Haider J. Warraich, Duane S. Pinto
Radial Versus Femoral Access for Percutaneous Coronary Intervention: Implications for Vascular Complications and Bleeding
- Management of Acute Coronary Syndromes (R Mehran, Section Editor)
Sandeep Nathan, Sunil V. Rao
Risk Stratification and Timing of Revascularization: Which Patients Benefit from Early Versus Later Revascularization?
- Management of Acute Coronary Syndromes (R Mehran, Section Editor)
Ian J. Sarembock, Dean J. Kereiakes
Is There Attenuation of Benefit of Invasive Therapy in Patients with Chronic Kidney Disease? Results from Randomized Trials and Registry Data
- Management of Acute Coronary Syndromes (R Mehran, Section Editor)
Jennifer Yu, Sze-Yuan Ooi, Ziad Sergie, Usman Baber
Multivessel Versus Culprit-Only Revascularization: One Time Versus Staged Procedures for the ACS Population
- Management of Acute Coronary Syndromes (R Mehran, Section Editor)
Pablo Codner, Ran Kornowski